Literature DB >> 25445943

The changing landscape of pulmonary arterial hypertension and implications for patient care.

Marius M Hoeper1, J Simon R Gibbs2.   

Abstract

Registries have provided a wealth of information on the clinical and disease characteristics of patients living with pulmonary arterial hypertension (PAH) since the 1980s. Certain PAH demographics, such as the prevalence of various PAH subgroups and preponderance of female patients, appear to have remained stable over time. Contemporary registry data indicate that the average age of patients diagnosed with PAH has increased, at least in the Western world. Older patients with PAH are more likely to be diagnosed with a more advanced stage of the disease, have lower exercise capacity and present with multiple comorbidities. They also have worse survival compared with younger patients. Within the PAH population, there is also a subset of patients with a lower diffusing capacity of the lung for carbon monoxide who are generally older and display more severe disease characteristics. This review discusses the implications that the increased age of the PAH population at diagnosis has on the treatment and management of the disease, as well as the need for earlier and improved diagnosis in these patients. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25445943     DOI: 10.1183/09059180.00007814

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  39 in total

1.  The Changing Landscape of Pulmonary Arterial Hypertension in 21st Century.

Authors:  Kuo Yang Wang
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

2.  Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center.

Authors:  Hongyang Pi; Chad M Kosanovich; Adam Handen; Michael Tao; Jacqueline Visina; Gabrielle Vanspeybroeck; Marc A Simon; Michael G Risbano; Aken Desai; Michael A Mathier; Belinda N Rivera-Lebron; Quyen Nguyen; Jennifer Kliner; Mehdi Nouraie; Stephen Y Chan
Journal:  Chest       Date:  2020-02-25       Impact factor: 9.410

Review 3.  Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.

Authors:  Ping Yu Xiong; Francois Potus; Winnie Chan; Stephen L Archer
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

Review 4.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

5.  Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.

Authors:  Jason H Karnes; Howard W Wiener; Tae-Hwi Schwantes-An; Balaji Natarajan; Andrew J Sweatt; Abhishek Chaturvedi; Amit Arora; Ken Batai; Vineet Nair; Heidi E Steiner; Jason B Giles; Jeffrey Yu; Maryam Hosseini; Michael W Pauciulo; Katie A Lutz; Anna W Coleman; Jeremy Feldman; Rebecca Vanderpool; Haiyang Tang; Joe G N Garcia; Jason X-J Yuan; Rick Kittles; Vinicio de Jesus Perez; Roham T Zamanian; Franz Rischard; Hemant K Tiwari; William C Nichols; Raymond L Benza; Ankit A Desai
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

Review 6.  Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.

Authors:  Christian Michael Perez; Quentin Felty
Journal:  Microvasc Res       Date:  2022-02-07       Impact factor: 3.514

7.  Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male mice.

Authors:  Sachindra Raj Joshi; Anand Lakhkar; Vidhi Dhagia; Ariadne L Zias; Vasiliki Soldatos; Kaori Oshima; Houli Jiang; Katherine Gotlinger; Jorge H Capdevila; Michal L Schwartzman; Ivan F McMurtry; Sachin A Gupte
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

8.  Inpatient Palliative Care Use in Patients With Pulmonary Arterial Hypertension: Temporal Trends, Predictors, and Outcomes.

Authors:  Vidhu Anand; Saraschandra Vallabhajosyula; Wisit Cheungpasitporn; Robert P Frantz; Hector R Cajigas; Jacob J Strand; Hilary M DuBrock
Journal:  Chest       Date:  2020-08-12       Impact factor: 9.410

9.  Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study.

Authors:  Nadine Al-Naamani; Hao-Min Pan; Michaela R Anderson; Drew A Torigian; Yubing Tong; Michelle Oyster; Mary K Porteous; Scott Palmer; Selim M Arcasoy; Joshua M Diamond; Jayaram K Udupa; Jason D Christie; David J Lederer; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2020-11

10.  Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.

Authors:  Marina Zemskova; Nolan McClain; Maki Niihori; Mathews V Varghese; Joel James; Ruslan Rafikov; Olga Rafikova
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.